Table 3.

G. mellonella in novel drugs testing and toxicity screening.

Compound	Antimicrobial target/drug evaluation	Reference
2-aminoimidazole containing urea	Acinetobacter baumannii	[82]
1,2,4-triazolidine-3-thiones derivates	Acinetobacter baumannii	[83]
Aminoglycoside 6′-N-acetyltransferase type Ib [AAC(6ʹ)-Ib] inhibitory	Acinetobacter baumannii and Klebsiella pneumoniae	[84]
1,2-benzisoselenazol-3(2H)-one derivatives	Enterobacter cloacae	[85]
Steroid-Au(I)-NHC Complexes	Escherichia coli	[86]
[S,S]-ethylenediamine-N,N’-disuccinic acid (EDDS)	Klebsiella pneumoniae	[87]
bis-2-aminoimidazole derivative and azithromycin association	Pseudomonas aeruginosa	[88]
Silver(I) complex	Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus and Candida albicans	[89]
Tobramycin−lysine conjugates	Pseudomonas aeruginosa	[90]
Hybrid antibiotic tobramycin−moxifloxacin hybrid core structure	Pseudomonas aeruginosa	[91]
Marine sponge-derived Streptomyces sp. SBT348 extract	Staphylococcus aureus	[92]
1-(4-chlorophenyl)-4,4,4-trifluoro-3-hydroxy-2-buten-1-one	Staphylococcus aureus	[93]
N-phenyl-1H-pyrazole-4-carboxamide derivatives	Staphylococcus aureus	[94]
1,2,3-Triazole/Sulfonate Analogues	Toxicity screening	[95]
Quinoline thiourea compound	Toxicity screening	[96]
Extract from the pulp of Eugenia brasiliensis Lam. (Myrtaceae)	Toxicity screening	[97]
Thiazolylhydrazone derivatives	Toxicity screening	[98]